Population Health Investment Co Inc Units (1 Ord Share Class A & 1/3 War) PHICU 深 沪
等待开盘 11-05 09:30:00 美东时间
10.03
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 10.03
- 总市值 18.81万
- 52周最高 10.307
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.80
- 委 比 0.00%
- 总股本 1.88万
- 历史最高 11.835
- 量 比 0
- 振 幅 0.00%
- 历史最低 9.80
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多WTW 2026 Best Practices in Healthcare Survey: U.S. employer healthcare costs set to rise at fastest pace in more than two decades
US employers face rising healthcare costs, with pharmacy expenses up 11.5% and employer satisfaction with PBMs dropping. Nearly half of employers plan significant healthcare changes within three years, including cost-shifting and reevaluating vendor performance. Employees may face higher out-of-pocket costs, while employers prioritize multi-year strategies to manage high-cost risks and improve program value.
10-28 14:03
恩华药业自主研发1类创新药项目达成海外合作，潜在价值超5亿美元
2026年9月29日，江苏恩华药业股份有限公司（以下简称“恩华药业”）宣布与美国Somnivera, Inc.（以下简称“Somnivera”）就一款处于临床阶...
09-29 18:47
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
DeepHealth, Inc. has received FDA 510(k) clearances for two new Breast Suite functionalities: Breast Arterial Calcification (BAC) Assessment, which identifies potential early indicators of cardiovascular disease, and Mammo Dx, which integrates prior exams to improve cancer detection and reduce recalls. These additions enhance Breast Suite as a comprehensive AI solution for breast imaging, providing radiologists with a more complete patient overvi...
06-25 10:00
Strong biopharma dealmaking market set to continue
The strong trend in pharma and biotech dealmaking, which has been ongoing for several years, should continue according to experts. Speaking at the FT US Pharma and Biotech Summit in New York, Eric Tok...
05-15 01:41
Radnet's Subsidiary Deephealth Unveils At ECR 2026 Portfolio Of Native Clinical Ai Solutions And Services Across All Core Imaging Modalities
DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of native clinical AI
03-04 20:08
DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026
DeepHealth, a global leader in AI-powered health informatics, has unveiled its comprehensive AI portfolio at the 2026 European Congress of Radiology. The cloud-first platform integrates clinical AI tools across MR, CT, X-ray, mammography, and ultrasound, enhancing disease detection,Diagnostic accuracy, and workflow efficiency. Key offerings include Breast Suite, Chest Suite, Neuro Suite, Prostate Suite, and Thyroid Suite, supported by AI Studio f...
03-04 12:00
From Elon's X To Weight-Loss Rx: Linda Yaccarino's 'Milestone Day' With Aon
A telehealth company led by former X CEO Linda Yaccarino announced major news Monday.
2025-08-19 04:18
